Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Hiromi Ihara"'
Autor:
Hidekatsu Sakata, Shinichiro Sato, Kenji Tadokoro, Akemi Wakisaka, Hisami Ikeda, Sally A. Baylis, Shigeru Takamoto, Mei-ying W. Yu, Keiji Matsubayashi, Toshiaki Kato, Hiromi Ihara
Publikováno v:
Transfusion. 53:2556-2566
Background To reduce the risk of human parvovirus B19 (B19V) transmission through contaminated blood for transfusion and plasma-derived products, the Japanese Red Cross (JRC) Blood Centers introduced B19V antigen screening by chemiluminescent enzyme
Autor:
Keiji Matsubayashi, Shinichi Kishimoto, Hiromi Takeda, Hidekatsu Sakata, Kenji Tadokoro, Hisami Ikeda, Toshiaki Kato, Hiromi Ihara, Shinichiro Sato
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 57:146-152
【背景】日赤では,輸血用血液や血漿分画製剤原料へのヒトパルボウイルスB19(B19V)の混入を防止するため,化学発光酵素免疫測定法(chemiluminescence enzyme immunoassay:CLEIA)によるB19V抗原
A SENSITIVE CHEMILUMINESCENCE ENZYME IMMUNOASSAY FOR DONOR SCREENING OF HUMAN PARVOVIRUS B19 ANTIGEN
Autor:
Keiji Matsubayashi, Shinichiro Sato, Hidekatsu Sakata, Hiromi Takeda, Toshiaki Kato, Hiromi Ihara, Naohito Sakagami, Hisami Ikeda
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 53:467-472
ヒトパルボウイルスB19 (以下B19) に感染した人の献血によって, B19が輸血用血液や分画原料血漿に混入し, 更にその製剤を介して患者にB19が感染する可能性がある. その危険性を減少させる
Autor:
Sadamitsu Yamamoto, Hideya Hasegawa, Shinichiro Sato, Shinichi Sakaya, Hisami Ikeda, Toshiaki Kato, Hiromi Ihara
Publikováno v:
Journal of the Japan Society of Blood Transfusion. 47:395-402
Autor:
C.H. Dash, Bernard Burnand, Sadayoshi Sekiguchi, Ana Abad, Gerhard Mertens, Lennart Rydberg, Henning Sørensen, Céline Kiener, Anders Elmgren, Takanori Oka, Akio Yamane, Koki Fujiwara, Göran Larson, Shigeki Mitsunaga, Anne Catrine Simonsen, Jean-Daniel Tissot, Katsushi Tokunaga, T. Kato, Tatsuya Akaza, Lars Hynsjö, Yoichi Shibata, E. Gascoigne, Yoshihisa Watanabe, Hiromi Ihara, Pedro J. Tárraga López, Sandra Heylen, John More, Lola Svensson, S. Sato, Kenji Tadokoro, Philippe Schneider, K. Chidwick, Ludo Muylle, N. Briggs, Javier Bauza, T. Vervoort, Hisami Ikeda, Hiroshi Sakata, Takeo Juji, P. Matejtschuk
Publikováno v:
Vox Sanguinis. 77:239-250
Autor:
Hidekatsu, Sakata, Keiji, Matsubayashi, Hiromi, Ihara, Shinichiro, Sato, Toshiaki, Kato, Akemi, Wakisaka, Kenji, Tadokoro, Mei-ying W, Yu, Sally A, Baylis, Hisami, Ikeda, Shigeru, Takamoto
Publikováno v:
Transfusion. 53(10 Pt 2)
To reduce the risk of human parvovirus B19 (B19V) transmission through contaminated blood for transfusion and plasma-derived products, the Japanese Red Cross (JRC) Blood Centers introduced B19V antigen screening by chemiluminescent enzyme immunoassay
Publikováno v:
Journal of the American Chemical Society. 133(10)
Infectious hepatitis B virus (HBV), namely Dane particles (DPs), consists of a core nucleocapsid including genome DNA covered with an envelope of hepatitis B surface antigen (HBsAg). We report the synthesis, structure, and HBV-trapping capability of
Publikováno v:
Journal of the Japan Society of Blood Transfusion. 38:429-434
Hepatitis B virus DNA (HBV-DNA) in 391 anti-HBc positive blood samples were tested by nested polymerase chain reaction. DNA was prepared from pellets of plasma samples after ultra-centri fugation.Of 135 HBsAg weakly positive samples, 127 (93.3%) were
Publikováno v:
Journal of the Japan Society of Blood Transfusion. 36:56-62
The hemagglutination inhibition (HI) method was evaluated as a screening test of antibodies to hepatitis B core antigens (anti-HBc).Of 1000 donors samples tested, 272 were HI-positive which included all the anti-HBc positive samples by EIA. Five samp
Autor:
Hisami Ikeda, Toshiaki Kato, Hiromi Ihara, Hiroshi Azuma, Hidekatsu Sakata, Kenji Ikebuchi, Takashi Owada, Shinichiro Sato, Keiji Matsubayashi
Publikováno v:
Journal of viral hepatitis. 13(1)
The cellular receptor for hepatitis B virus (HBV) infection has not yet been identified. The purpose of this study was to address the possibility of participation by desialylated HBV and the asialoglycoprotein receptor (ASGP-R) exclusively expressed